VitaPCR COVID-19 assay
Manufactured by Credo Diagnostics Biomedical, Singapore - www.credodxbiomed.com/
Device identification number
141
CE Marking
✓Yes
HSC common list (RAT)
×No
Format
Lab-based
Target type
Nucleic acid
Commercial Status
Commercialised
Last Update
2022-08-24 09:08:01 CET
Comments
virus nucleocapsid (N) gene.
Assay Type
Nucleic acid-PCR
Method
RT-PCR
Time
20 minutes
Throughput
one sample well
Notes
https://www.menarinidiagnostics.it/en-us/Home/Laboratory-Products/COVID-19/VitaPCRTM-platform/Learn-More
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements